Otani, Naoyuki
Toyoda, Shigeru
Sakuma, Masashi
Hayashi, Keitaro
Ouchi, Motoshi
Fujita, Tomoe
Anzai, Naohiko
Tanaka, Atsushi
Node, Koichi
Uemura, Naoto
Inoue, Teruo
Article History
Received: 27 May 2017
Revised: 6 April 2018
Accepted: 10 April 2018
First Online: 5 September 2018
Compliance with ethical standards
:
: Employment: NU (RIKEN, Osaka University, Merck, Takeda, OPKO Health Inc, Ono Pharmaceutical Co., Ltd., Sato Pharmaceutical Co., Ltd., Seren Pharmaceuticals Inc., Bonac Corp.); Stock: NU (Merck); Honoraria: TI (Mochida, Bayer, Boehringer Ingelheim), KN (Daiichi Sankyo, Merck, Phizer, Eli Lilly, Astellas Pharma, Boehringer Ingelheim, Mitsubishi Tanabe Pharma); Research funding: NU (AMED, Fukuoka Prefecture), KN (Bayer, TEIJIN PHARMA, Mitsubishi Tanabe Pharma); Scholarship or donation: KN (Astellas Pharma, Daiichi Sankyo,Sumitomo Dainippon Pharma, Takeda, Mitsubishi Tanabe Pharma, Boehringer Ingelheim). The remaining authors declare that they have no conflict of interest.